Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scrip Team

Latest From Scrip Team

Pipeline Watch: Eight Approvals And 12 Phase III Trial Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Executives On The Move: UCB, LAVA Therapeutics and More

Recent executive moves in the industry include C-suite changes at Arcus Biosciences and UCB. Meanwhile, new directors were appointed at Arovella Therapeutics and LAVA Therapeutics.

Executive Changes Leadership

Pipeline Watch: ACC Meeting Dominates Clinical Updates Plus Four New Approvals

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Clinical Trials

Executives On The Move: Changes At Albireo Pharma, AbbVie And Lundbeck

Recent executive moves in the industry include C-suite changes at Albireo Pharma, Aptevo Therapeutics and AbbVie. Meanwhile, new directors were appointed at Amarin and Oculis Holding.

Executive Changes Leadership

Pipeline Watch: Seven Approvals And 15 Phase III Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Executives On The Move: Avidity Biosciences, Exicure and More

Recent executive moves in the industry include C-suite changes at Avidity Biosciences and BioAtla. Meanwhile, new directors were appointed at Exicure and Alimera Sciences.

Executive Changes Leadership
See All
UsernamePublicRestriction

Register